Menu Search
Equities

SynAct Pharma AB

8F8:STU

SynAct Pharma AB

Actions
  • Price (EUR)0.7125
  • Today's Change0.005 / 0.71%
  • Shares traded0.00
  • 1 Year change+27.92%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in SEKView more

In 2023, cash reserves at SynAct Pharma AB fell by 45.85m. Cash Flow from Financing totalled 53.98m or -- of revenues. In addition the company used 100.18m for operations while cash from investing totalled 370.00k.
Cash flow per share--
Price/Cash flow per share--
Book value per share4.10
Tangible book value per share0.4152
More ▼

Balance sheet in SEKView more

SynAct Pharma AB has little financial risk as the capital structure does not rely on leverage.
Current ratio3.88
Quick ratio--
Total debt/total equity0.0084
Total debt/total capital0.0084
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.